176 related articles for article (PubMed ID: 34409490)
1. Unusual split green-orange signals in USP6 fluorescence in situ hybridization in a malignant peripheral nerve sheath tumor with a novel NF1-SCIMP fusion: a potential diagnostic pitfall.
Qiu Y; Jing W; Zhou Y; Chen H; Chen M; Zhang H
Virchows Arch; 2022 Jun; 480(6):1255-1260. PubMed ID: 34409490
[TBL] [Abstract][Full Text] [Related]
2. Unknown partner for USP6 and unusual SS18 rearrangement detected by fluorescence in situ hybridization in a solid aneurysmal bone cyst.
Geiersbach K; Rector LS; Sederberg M; Hooker A; Randall RL; Schiffman JD; South ST
Cancer Genet; 2011 Apr; 204(4):195-202. PubMed ID: 21536237
[TBL] [Abstract][Full Text] [Related]
3. Atypical nodular fasciitis with a novel PAFAH1B1-USP6 fusion in a 22-month-old boy.
Qiu Y; Peng R; Chen H; Zhuang H; He X; Zhang H
Virchows Arch; 2021 Sep; 479(3):623-629. PubMed ID: 33161462
[TBL] [Abstract][Full Text] [Related]
4. Malignant peripheral nerve sheath tumor on a patient with a maternally inherited novel NF1 gene pathogenic germline variant: Case report.
Moreno-Salgado R; Rios-Lozano YZ; Tamayo-Palacio AC; Castillo AI; Hidalgo-Martínez MF
Cancer Genet; 2023 Jun; 274-275():72-74. PubMed ID: 37087941
[TBL] [Abstract][Full Text] [Related]
5. Assessment of H3K27me3 immunohistochemistry and combination of NF1 and p16 deletions by fluorescence in situ hybridization in the differential diagnosis of malignant peripheral nerve sheath tumor and its histological mimics.
Sugita S; Aoyama T; Emori M; Kido T; Takenami T; Sakuraba K; Terai K; Sugawara T; Tsujiwaki M; Hasegawa T
Diagn Pathol; 2021 Aug; 16(1):79. PubMed ID: 34461930
[TBL] [Abstract][Full Text] [Related]
6. Fusion of the Lumican (
Panagopoulos I; Gorunova L; Andersen K; Lobmaier I; Lund-Iversen M; Micci F; Heim S
Cancer Genomics Proteomics; 2020; 17(5):555-561. PubMed ID: 32859633
[TBL] [Abstract][Full Text] [Related]
7. Circulating tumor DNA for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Jones J; Cain S; Pesic-Smith J; Choong PFM; Morokoff AP; Drummond KJ; Dabscheck G
J Neurooncol; 2021 Sep; 154(3):265-274. PubMed ID: 34529228
[TBL] [Abstract][Full Text] [Related]
8. Intraneural Nodular Fasciitis of the Femoral Nerve with A Unique
Parkinson B; Patton A; Rogers A; Farhadi HF; Oghumu S; Iwenofu OH
Int J Surg Pathol; 2022 Sep; 30(6):673-681. PubMed ID: 35175167
[TBL] [Abstract][Full Text] [Related]
9. Different sized somatic NF1 locus rearrangements in neurofibromatosis 1-associated malignant peripheral nerve sheath tumors.
Pasmant E; Vidaud D; Harrison M; Upadhyaya M
J Neurooncol; 2011 May; 102(3):341-6. PubMed ID: 20686819
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
[TBL] [Abstract][Full Text] [Related]
11. USP6 genetic rearrangements in cellular fibroma of tendon sheath.
Carter JM; Wang X; Dong J; Westendorf J; Chou MM; Oliveira AM
Mod Pathol; 2016 Aug; 29(8):865-9. PubMed ID: 27125357
[TBL] [Abstract][Full Text] [Related]
12. Novel CTNNB1-USP6 fusion in intravascular fasciitis of the large vein identified by next-generation sequencing.
Lu Y; He X; Qiu Y; Chen H; Zhuang H; Yao J; Zhang H
Virchows Arch; 2020 Sep; 477(3):455-459. PubMed ID: 32170450
[TBL] [Abstract][Full Text] [Related]
13. Elevated risk for MPNST in NF1 microdeletion patients.
De Raedt T; Brems H; Wolkenstein P; Vidaud D; Pilotti S; Perrone F; Mautner V; Frahm S; Sciot R; Legius E
Am J Hum Genet; 2003 May; 72(5):1288-92. PubMed ID: 12660952
[TBL] [Abstract][Full Text] [Related]
14. RNA sequencing identifies a novel USP9X-USP6 promoter swap gene fusion in a primary aneurysmal bone cyst.
Blackburn PR; Davila JI; Jackson RA; Fadra N; Atiq MA; Pitel BA; Nair AA; VanDeWalker TJ; Hessler MG; Hovel SK; Wehrs RN; Fritchie KJ; Jenkins RB; Halling KC; Geiersbach KB
Genes Chromosomes Cancer; 2019 Aug; 58(8):589-594. PubMed ID: 30767316
[TBL] [Abstract][Full Text] [Related]
15. Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy.
Bhandarkar AR; Bhandarkar S; Babovic-Vuksanovic D; Parney IF; Spinner RJ
J Neurooncol; 2023 Sep; 164(3):693-699. PubMed ID: 37755632
[TBL] [Abstract][Full Text] [Related]
16. [Fibroma of tendon sheath: a clinicopathological and genetic analysis of 134 cases].
Cui J; Lu Y; Qiu Y; He X; Chen M; Zhang HY
Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):364-369. PubMed ID: 36973197
[No Abstract] [Full Text] [Related]
17. Constitutional NF1 mutations in neurofibromatosis 1 patients with malignant peripheral nerve sheath tumors.
Kluwe L; Friedrich RE; Peiper M; Friedman J; Mautner VF
Hum Mutat; 2003 Nov; 22(5):420. PubMed ID: 14517963
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide high-resolution analysis of DNA copy number alterations in NF1-associated malignant peripheral nerve sheath tumors using 32K BAC array.
Mantripragada KK; Díaz de Ståhl T; Patridge C; Menzel U; Andersson R; Chuzhanova N; Kluwe L; Guha A; Mautner V; Dumanski JP; Upadhyaya M
Genes Chromosomes Cancer; 2009 Oct; 48(10):897-907. PubMed ID: 19603524
[TBL] [Abstract][Full Text] [Related]
19. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
20. Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors.
Park SJ; Sawitzki B; Kluwe L; Mautner VF; Holtkamp N; Kurtz A
BMC Med; 2013 Apr; 11():109. PubMed ID: 23618374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
